The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: The healthy man study
Abstract
Summary: Objective: To determine serum concentrations, intra‐individual variability and impact of age‐related co‐morbidities on serum testosterone (T), dihydrotestosterone (DHT), estradiol (E 2) and estrone (E 1) in older men. Design: Observational, repeated measures study. Participants: Men (n = 325) with 40 years and older self‐reporting very good or excellent health. Measurements: Standardized history, physical examination and collection of nine blood samples at fixed time intervals were measured over 3 months (three at 20 min intervals on days 1 (fasting) and 2 (non‐fasting), one at days 7, 30 and 90). Serum T, DHT, E 2 and E 1 (n = 2900, > 99% of scheduled samples) measured by liquid chromatography‐tandem mass spectrometry (LC‐MS) were analysed by linear mixed model analysis with fasting, age and obesity as covariables. Results: Mean serum T did not vary with age (P = 0·76) but obesity (−0·35 n m per body mass index (BMI) unit, P < 0·0001) and ex‐smoker status (−1·6 n m, P < 0·001) had significant effects. Serum DHT was increased with age (+0·011 n m per year, P = 0·001) but decreased with obesity (−0·05 n m per BMI unit, P < 0·0001). Serum E 2 did not vary with age (P = 0·31) or obesity (P = 0·12). Overnight fasting increased (by 9–16%, all P < 0·001) and reduced variability in morning serum T, DHT, E 2 and E 1. Non‐fasting serum T and DHT were stable over time (day, week, month or 3 months; P > 0·28). Conclusions: Serum T, DHT and E 2 displayed no decrease associated with age among men over 40 years of age who self‐report very good or excellent health although obesity and ex‐smoking status were associated with decreased serum androgens (T and DHT) but not E 2. These findings support the interpretation that the age‐related decline in blood T accompanying non‐specific symptoms in older men may be due to accumulating age‐related co‐morbidities rather than a symptomatic androgen deficiency state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, there is increasing evidence that healthy ageing by itself is uncommonly associated with marked reductions in testosterone levels.23”
From Lowered testosterone in male obesity: Mechanisms, morbidity and management (2014) · cites this paper as [23]
In the citing paper
“Early studies comparing young (mean age 25–27 years) versus elderly males (mean age 71 years) demonstrated peak T concentrations in the 3–8 AM time period (extended to 2 PM in elderly males), with trough levels noted in the early afternoon to late evening.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [43]
In the citing paper
“T levels exhibit time, sleep, and age-dependent circadian variations.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [43]
In the citing paper
“Despite similar patterns of variation throughout the day, elderly males experienced significant blunting of peak versus trough levels, with differences in high and low values of 61–205 ng/dl (2.1–7.1 nmol/L) compared to 141–354 ng/dl (4.9–12.3 nmol/L) in younger men.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [43]
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cameron, A. J., Zimmet, P., Dunstan, D. W., Dalton, M., Shaw, J. E., Welborn, T. A., Owen, N. G., Salmon, J., & Jolley, D. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05283.x · Cited by 595
Association of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Zitzmann, M., Faber, S., & Nieschlag, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0401 · Cited by 552
Cameron, A. J., Zimmet, P., Dunstan, D. W., Dalton, M. F., Shaw, J. E., Welborn, T. A., Owen, N. G., Salmon, J., & Jolley, D. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05998.x · Cited by 537
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J. J., Lunenfeld, B., Morales, Á., et al. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.006486 · Cited by 443
HARMAN, S. M., & TSITOURAS, P. D. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-1-35 · Cited by 370
Reproductive Functions in Young Fathers and Grandfathers
Nieschlag, E., LAMMERS, U., Freischem, C. W., Langer, K., & Wickings, E. J. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-676 · Cited by 312
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–208 of 208
Testosteron und kardiovaskuläre Effekte
Yeap, B. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_19
Missbrauch und Missbrauch von Testosteron
Iyer, R., & Handelsman, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_23
Self-citationMännlicher Hypogonadismus und Alterung: ein Update
Iglesias, P., Núñez, A., & Díez, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_9
Zhao, J. V., & Schooling, C. M. (2020) · Figshare · doi:10.6084/m9.figshare.12422294
Management of Primary Hypogonadism in Men with NOA
Böcü, K., & Gül, M. (2026) · Springer eBooks · doi:10.1007/978-3-031-99431-9_6
Goulian, A. J., Ashkezari, A., & Eleswarapu, S. V. (2026) · American Journal of Men s Health · doi:10.1177/15579883261433808
Osmancevic, A., Li, Y., Ottarsdottir, K., Hellgren, M. I., Lindblad, U., Allison, M., Trimpou, P., Kokelj, S., & Daka, B. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1882696
Andersen, M. L., SANCHES, J. B., Alvarenga, T. A., Toricelli, M., Vasco, M. B., & Tufik, S. E. R. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02981-6
Metadata
- Authors
- Sartorius, G., Spasevska, S., Idan, A., Turner, L., Forbes, E., Zamojska, A., Allan, C. A., Ly, L. P., Conway, A. J., McLachlan, R. I., & Handelsman, D. J.
- Affiliations
- The University of Sydney (AU)
- Concord Hospital (US)
- Prince Henrys Institute Clayton
- Corresponding author
- Handelsman, David J.
- ORCID
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2012-10-05
- Volume
- 77
- Issue
- 5
- Pages
- 755-763
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1984060669
- Cited by
- 209
- References
- 41
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 5 · 2023: 24 · 2022: 9 · 2021: 10 · 2020: 14 · 2019: 14 · 2018: 12 · 2017: 16 · 2016: 26 · 2015: 23 · 2014: 23 · 2013: 18 · 2012: 4
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bupa Foundation
- Bupa Health Foundation
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- serum testosterone, dihydrotestosterone, estradiol, estrone, older men, aging, obesity, smoking, fasting effects, diurnal variation, androgen levels, healthy aging
- MeSH terms
- Aged, Estradiol, Humans, Male, Middle Aged, Dihydrotestosterone, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
